Cauley J A, Gutai J P, Kuller L H, Powell J G
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, PA.
Am J Epidemiol. 1990 Nov;132(5):884-94. doi: 10.1093/oxfordjournals.aje.a115731.
The relation of concentrations of endogenous estrogens and androgens to lipid and lipoprotein levels was examined in 176 white, postmenopausal women (mean age, 58 years) with an average of 9 years since the onset of menopause. All of the women were participants in a clinical trial of the effect of walking on postmenopausal bone loss. In that trial, women were randomized into either a walking group or a control group and were followed for 3 years. There were no differences in the serum hormones or lipids by randomized group, and hence, results from this study are presented for both groups combined. None of the women were on estrogen replacement therapy. Data were available from year 1 (1982-1983) of the trial for the estrogens, lipids, and lipoproteins. Information on androgens was available for 143 of these women. Hormone levels were determined by highly specific methods involving extraction, column chromatography, and radioimmunoassay. About 50% of the women had estradiol levels at or below the sensitivity level (2.5 pg/ml) of the assay; therefore, estradiol levels were viewed as dichotomous (measurable/not measurable), and the estradiol results should be interpreted with caution. There was little relation of the androgens to the lipid values. Univariate analyses suggested a direct relation between total cholesterol, low density lipoprotein cholesterol, and triglyceride levels with estradiol. An inverse relation was suggested between serum estrone and estradiol and total high density lipoprotein (HDL) cholesterol and HDL2 cholesterol, although none of these associations were statistically significant. Multiple regression analyses revealed that the primary determinant of the HDL cholesterol and triglyceride levels was the degree of obesity as estimated by the body mass index (weight (kg)/height (m)2). Addition of estrone or estradiol to the models did not contribute to the prediction of lipid levels. These results do not support the hypothesis of there being a relation between endogenous sex hormone levels and lipid levels in postmenopausal women. The results suggest that sex hormones cannot explain the sex difference in lipid levels and may not contribute to the rise in coronary heart disease that occurs in women around menopause.
在176名绝经后白人女性(平均年龄58岁,绝经平均9年)中,研究了内源性雌激素和雄激素浓度与血脂及脂蛋白水平之间的关系。所有这些女性均参与了一项关于步行对绝经后骨质流失影响的临床试验。在该试验中,女性被随机分为步行组或对照组,并随访3年。随机分组后,两组的血清激素或血脂水平并无差异,因此,本研究结果为两组合并后的结果。所有女性均未接受雌激素替代疗法。试验第1年(1982 - 1983年)可获取雌激素、血脂和脂蛋白的数据。其中143名女性可获取雄激素信息。激素水平通过涉及提取、柱色谱和放射免疫测定的高特异性方法测定。约50%的女性雌二醇水平处于或低于该检测方法的灵敏度水平(2.5 pg/ml);因此,雌二醇水平被视为二分变量(可测/不可测),对雌二醇结果的解读应谨慎。雄激素与血脂值之间几乎没有关联。单变量分析表明总胆固醇、低密度脂蛋白胆固醇和甘油三酯水平与雌二醇之间存在直接关系。血清雌酮和雌二醇与总高密度脂蛋白(HDL)胆固醇和HDL2胆固醇之间存在负相关关系,尽管这些关联均无统计学意义。多元回归分析显示,高密度脂蛋白胆固醇和甘油三酯水平的主要决定因素是通过体重指数(体重(kg)/身高(m)²)估算的肥胖程度。在模型中加入雌酮或雌二醇并不能有助于预测血脂水平。这些结果不支持绝经后女性内源性性激素水平与血脂水平之间存在关联的假设。结果表明,性激素无法解释血脂水平的性别差异,可能也不会导致绝经前后女性冠心病发病率的上升。